Yousif Capital Management LLC reduced its position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing ...
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results